Literature DB >> 8034581

Granule serine proteases are normal nuclear constituents of natural killer cells.

J A Trapani1, M J Smyth, V A Apostolidis, M Dawson, K A Browne.   

Abstract

One mechanism by which cytotoxic T lymphocytes and natural killer cells inflict target cell death depends upon secreting the contents of their specialized cytoplasmic granules, containing a pore-forming protein, perforin, and a family of homologous serine proteases ("granzymes") with various enzyme activities. We used a granzyme B-specific mouse anti-human monoclonal antibody 2C5 and Western blotting to demonstrate that nuclear extracts of human interleukin-2-stimulated peripheral blood mononuclear cells, the human NK leukemia cell line YT, and the rat NK leukemia cell line RNK-16 contain abundant granzyme B. In interleukin-2-activated peripheral blood mononuclear cells, more than 50% of the total cellular granzyme B was present in the nuclear lysate. Nuclear granzyme B had an apparent molecular mass of approximately 32 kDa in human cells and approximately 30 kDa in RNK-16 and was eluted from immobilized heparin at the same NaCl concentration as granzyme B from cytoplasmic granules. Granzyme B that was affinity-purified with 2C5 from the nuclei of YT or human LAK cells was capable of efficiently cleaving synthetic peptide thiobenzyl ester substrates with the same specificity (peptide cleavage after aspartic acid) as granule-localized granzyme B. By contrast perforin, which colocalizes with granzymes in cytotoxic granules, was not detectable in nuclear lysates. Granzyme B was also demonstrated to be present in the nucleus and cytoplasmic granules of YT by immunohistochemical staining with monospecific anti-granzyme B antisera. Other protease activities (tryptase and peptide cleavage after methionine) were also readily detectable in nuclear and cytoplasmic lysates of YT, RNK-16, and LAK cells, as determined by the cleavage of the synthetic substrates N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT) and Boc-Ala-Ala-Met-S-benzyl, except that BLT-esterase activity was absent from the nucleus of YT. The localization of serine proteases in the nucleus was restricted to lymphocytes with cytotoxic capacity, as non-cytotoxic cell lines expressed high levels of peptide cleavage after methionine and tryptase activities in their cytoplasm, but possessed no nuclear serine protease activity. Furthermore, non-cytotoxic monkey kidney COS-7 cells transfected with an SV40-driven expression plasmid incorporating full-length human granzyme B cDNA contained abundant cytoplasmic granzyme B, but demonstrated minimal nuclear granzyme B accumulation. We conclude that serine proteases of NK cells are not restricted to cytolytic granules and, further, that their capacity to access the nucleus may have implications for the role of these enzymes in eliciting target cell death.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034581

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus.

Authors:  Orchi Dutta; Jorge A Masso-Silva; Keyi Wang; Amariliz Rivera
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

2.  Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1.

Authors:  C H Bird; E J Blink; C E Hirst; M S Buzza; P M Steele; J Sun; D A Jans; P I Bird
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.

Authors:  T Fernandes-Alnemri; R C Armstrong; J Krebs; S M Srinivasula; L Wang; F Bullrich; L C Fritz; J A Trapani; K J Tomaselli; G Litwack; E S Alnemri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  A colorimetric assay that specifically measures Granzyme B proteolytic activity: hydrolysis of Boc-Ala-Ala-Asp-S-Bzl.

Authors:  Magdalena Hagn; Vivien R Sutton; Joseph A Trapani
Journal:  J Vis Exp       Date:  2014-11-28       Impact factor: 1.355

6.  Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway.

Authors:  C H Bird; V R Sutton; J Sun; C E Hirst; A Novak; S Kumar; J A Trapani; P I Bird
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

7.  Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing.

Authors:  Q Song; S R Burrows; G Smith; S P Lees-Miller; S Kumar; D W Chan; J A Trapani; E Alnemri; G Litwack; H Lu; D J Moss; S Jackson; M F Lavin
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

8.  Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.

Authors:  Lawrence H Cheung; Yunli Zhao; Ana Alvarez-Cienfuegos; Khalid A Mohamedali; Yu J Cao; Walter N Hittelman; Michael G Rosenblum
Journal:  J Exp Clin Cancer Res       Date:  2019-07-30

9.  Expression of endogenous granzyme B in a subset of human primary breast carcinomas.

Authors:  S X Hu; S Wang; J P Wang; G B Mills; Y Zhou; H-J Xu
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.